- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 3 x CA: CALCIUM ION(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.2: 10 residues within 4Å:- Chain A: Y.754, W.760, F.802, L.813, L.934, F.935, A.937, N.938
- Chain D: C.963, L.967
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:W.760, A:L.813, A:L.934, A:F.935, A:F.935, A:A.937, D:L.967
- Hydrogen bonds: A:N.938
Y01.6: 11 residues within 4Å:- Chain B: L.955, F.959
- Chain C: W.753, Y.754, W.760, F.802, L.813, L.934, F.935, A.937, N.938
8 PLIP interactions:5 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:W.760, C:L.813, C:F.935, C:F.935, C:A.937, B:L.955, B:L.955, B:F.959
Y01.10: 6 residues within 4Å:- Chain D: Y.754, F.802, L.813, L.934, A.937, N.938
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:L.813, D:A.937
- Hydrogen bonds: D:N.938
- 4 x YZY: (2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
YZY.3: 14 residues within 4Å:- Chain A: L.952, F.958, Y.962, L.966, F.1007, Q.1011, F.1014, W.1015, V.1017
- Chain D: F.1037, A.1040, T.1041, T.1045, I.1049
10 PLIP interactions:9 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:L.952, A:F.958, A:Y.962, A:L.966, A:F.1007, A:F.1007, A:Q.1011, A:V.1017, D:I.1049
- Hydrogen bonds: A:W.1015
YZY.4: 15 residues within 4Å:- Chain A: F.1037, A.1040, T.1041, T.1045, I.1049
- Chain B: L.944, F.950, L.951, F.954, L.958, F.985, F.1002, F.1005, W.1006, I.1008
9 PLIP interactions:8 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:L.944, B:F.950, B:L.951, B:F.954, B:L.958, B:F.1002, B:I.1008, B:I.1008, A:I.1049
YZY.7: 15 residues within 4Å:- Chain C: F.1037, A.1040, T.1041, T.1045, I.1049
- Chain D: L.952, F.958, L.959, Y.962, L.966, F.1007, Q.1011, F.1014, W.1015, V.1017
10 PLIP interactions:8 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:L.952, D:F.958, D:L.959, D:L.966, D:F.1007, D:Q.1011, D:V.1017, C:T.1045, C:I.1049
- Hydrogen bonds: D:W.1015
YZY.8: 16 residues within 4Å:- Chain B: M.953, F.1030, A.1033, V.1034, T.1038, V.1041, V.1042, L.1047
- Chain C: L.948, F.958, Y.962, L.966, Q.1011, F.1014, W.1015, V.1017
13 PLIP interactions:9 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:L.948, C:F.958, C:Y.962, C:Y.962, C:Y.962, C:L.966, C:Q.1011, C:V.1017, B:V.1041, B:V.1041, B:V.1042, B:L.1047
- Hydrogen bonds: C:W.1015
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chen, Y.X. et al., Cryo-EM structure of the human TRPC1/C5 heteromer. To Be Published
- Release Date
- 2025-10-22
- Peptides
- Maltose/maltodextrin-binding periplasmic protein,Short transient receptor potential channel 5: ACD
Maltose/maltodextrin-binding periplasmic protein,Short transient receptor potential channel 1,Extended tegument protein pp150: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CD
DB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 3 x CA: CALCIUM ION(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x YZY: (2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chen, Y.X. et al., Cryo-EM structure of the human TRPC1/C5 heteromer. To Be Published
- Release Date
- 2025-10-22
- Peptides
- Maltose/maltodextrin-binding periplasmic protein,Short transient receptor potential channel 5: ACD
Maltose/maltodextrin-binding periplasmic protein,Short transient receptor potential channel 1,Extended tegument protein pp150: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CD
DB
B - Membrane
-
We predict this structure to be a membrane protein.